Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Issues Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $94.44 --0%
EPS Growth %: +10.4%
Financial Fact:
Net sales: 739.4M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
EPS Growth %: +10.4%
Financial Fact:
Net sales: 739.4M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.22, $0.10 better than the analyst estimate of $1.12. Revenue for the quarter came in at $938 million versus the consensus estimate of $932.25 million.
GUIDANCE:
Edwards Lifesciences sees FY2018 EPS of $4.50-$4.70, versus the consensus of $4.54.
Edwards Lifesciences sees FY2018 EPS of $1.05-$1.15, versus the consensus of $1.17.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Arbor Realty Trust (ABR) Misses Q3 EPS by 8c
- AbbVie (ABBV) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
